MGI gene sequencing company

Location: Home /  News Center

MGI’s Groundbreaking Ceremony Was as Held in Guanggu, Wuhan!

Release date:2020-10-26Writer:MGIViews:187Share

WUHAN, CHINA, October 26, 2020--MGI’s ground-breaking ceremony of “Intelligent Manufacturing and R&D Base" was officially launched in Guanggu Wuhan. The R&D Base is located at Shendun Road 2, East Lake New Technology Development Zone, Wuhan, with an infrastructure investment of 1.264 billion yuan and a total investment of 2.4 billion yuan. The project is expected to complete the first phase in 2022 with a total construction area of 86,000 square meters.

 

The ground-breaking ceremony of MGI’s “Intelligent Manufacturing and R&D Base

 

Wang Zhonglin, member of the Standing Committee of Hubei Provincial Party Committee and Secretary of Wuhan Municipal Party Committee, Zhou Xianwang, Deputy Secretary of Wuhan Municipal Party Committee and Mayor of Wuhan Municipal People's Government, Wang Xiangwang, member of the Standing Committee of Wuhan Municipal Party Committee and Secretary of The Party Working Committee of East Lake High-tech Zone and other leaders attended the ceremony. Wang Jian, Co-founder and Chairman of BGI Group, Liu Siqi, Co-founder and Supervisor of BGI Group, Du Huixian, Director of the International Working Committee of the China Biodiversity Conservation and Green Development Foundation, Senior Counsellor of the UN Secretariat and Chairman of the International Independent Advisory Panel of ICG Conference, Xu Xun, CEO and Executive Director of BGI Group, Director of BGI Research, Director of the International Planning & Development Center, and Mu Feng, CEO of MGI, participated in the ceremony.

 

Wang Zhonglin, member of the Standing Committee of the CPC Hubei Provincial Committee and Secretary of the CPC Wuhan Municipal Committee, announced the start of the project.

 

At the ground-breaking ceremony, Wang Zhonglin, member of the Standing Committee of the CPC Hubei Provincial Committee and Secretary of the CPC Wuhan Municipal Committee, announce the commencement of the project. Zhou Xianwang, Deputy Secretary of the CPC Wuhan Municipal Committee and Mayor of Wuhan, and Wang Xiangwang, member of the Standing Committee of the CPC Wuhan Municipal Committee and Secretary of the Working Committee of East Lake High-tech Zone, delivered a speech respectively.

 

 Zhou Xianwang, Deputy Secretary of the CPC Wuhan Municipal Committee and Mayor of Wuhan, is making a speech

Wang Xiangwang, member of the Standing Committee of Wuhan Municipal Committee and Secretary of the Working Committee of East Lake High-tech Zone, is making a speech

 

Wang Jian, Co-founder and Chairman of BGI Group, expressed his gratitude to the Wuhan Municipal Government for its strong support and introduced the overall situation of the project. He emphasized that Wuhan is a heroic city, which has always had an indissoluble bond with BGI, and BGI was also one of the earliest organizations to set up branches in Guanggu, Wuhan. Besides, BGI’s “Huo-Yan” laboratory, which provides strong scientific support for COVID-19 prevention and control, was first established in Guanggu, Wuhan.. The daily throughput of nucleic acid testing has increased from 10,000 to 30,000 to 100,000, and now it can reach as high as 1 million per day. If we can do millions of COVID-19 tests, we can do millions of cancer and birth defects screening. The epidemic has brought us unprecedented challenges as well as opportunities. In a great era, in this heroic city, we have confidence and full assurance to achieve this goal.

 

Wang Jian, co-founder and chairman of BGI Group, is making a speech

 

Founded in 2016, MGI has more than 1600 employees, 32% of whom are R&D personnel. MGI operates in 50 countries and regions. MGI is one of the three companies in the world that have the ability to independently develop and mass-produce clinical high-throughput gene sequencers. At present, MGI has 8 branches including Changchun, Wuhan, Qingdao, and Hongkong in China, Kobe in Japan, Dubai in UAE, Riga in Latvia, and San Jose in the USA.

 

Model display of MGI’s products

 

Notably, Wuhan is currently an important production base of MGI in China. With the commencement and construction of MGI's intelligent manufacturing and R&D base, MGI will continue to increase a high proportion of R&D investment and build a series of projects in Guanggu Wuhan. These projects include but are not limited to gene sequencer intelligent production base, gene sequencer supporting reagents and chip production base, and high-end intelligent equipment research center. These will also further consolidate Wuhan's position as an important production and R&D base of MGI.

 

Architectural rendering of MiGI’s “Intelligent Manufacturing and R&D Base”

 

“The life sciences and medical and health industries have always been highly valued by the Wuhan Municipal Government. We hope to establish a world-class production quality system in Wuhan, improve production and delivery capabilities, continuously break through technological limits, and insist on continuous strategic investment in cutting-edge basic research and key technologies. Today’s investment will be transformed into tomorrow’s core competitiveness, and through continuous technological transformation, we will provide an industry-leading digital life technology platform.” Said Mu Feng, CEO of MGI. “At the same time, with the domestically-made, independent and controllable core tools, we will drive the joint development of life sciences from scientific research to industry to people’s livelihood, and build an open, cooperative and win-win industrial ecosystem. We aim to promote life sciences to benefit the public’s health, the national economy, and people’s livelihood, and accelerate the realization of “innovative and intelligent manufacturing”.

 

The ground-breaking ceremony of MGI’s “Intelligent Manufacturing and R&D Base

 

Mei Yonghong, Director and Executive Vice President of BGI Group, Chairman of BGI Agriculture Group, Yang Shuang, Executive Vice President of BGI Group and Deputy Director of the Domestic Regional Planning and Development Center, Yu Dejian, President of MGI, Zhu Shida, Director of BGI Gene R&D Center and General Manager of Tumor Division, Jiang Hui, Chief Operating Officer of MGI, Liu Jian, Executive Vice President of MGI, Liu Bo, CFO of MGI, Zhang Wei, General Manager of Wuhan MGI, and Zhou Rui, General Manager of Hubei BGI Group, participated in the ground-breaking ceremony.